Current Trends in Genitourinary Malignancies
The Westin Pasadena
Pasadena, CA
October 31, 2009
| 7:30 am | Registration and Continental Breakfast |
| 7:50 am | Welcome and Introductions |
| Advances in Kidney Cancer | |
| 8:00 am | Presession Survey |
| 8:05 am | The Role of Surgery With New Therapeutic Regimens Monish Aron |
| 8:30 am | Treating Advanced Renal Cell Carcinoma: Integrating the Algorithm and Individualizing Therapy Robert A. Figlin |
| 8:55 am | Case-Based Panel Discussion |
| 9:20 am | Postsession Survey |
| 9:25 am | Break |
| Current Management of Prostate Cancer | |
| 9:40 am | Presession Survey |
| 9:45 am | Epidemiology, Screening, and Prevention of Prostate Cancer: A 2009 Update |
| 10:10 am | Management of PSA Relapse Mitchell Gross |
| 10:35 am | Androgen Deprivation Therapy: A 2009 Perspective Charles J. Ryan |
| 11:00 am | Immunotherapy for the Treatment of Prostate Cancer Tanya B. Dorff |
| 11:25 am | Can We Improve Upon Standard Taxane Therapy to Treat Metastatic Prostate Cancer? Nicholas J. Vogelzang |
| 11:50 am | Postsession Survey |
| 11:55 am | Break to Serve Lunch |
| 12:15 pm | Challenging Cases in Prostate Cancer: Interactive Panel Discussion |
| Current Approaches to Bladder Cancer | |
| 1:00 pm | Presession Survey |
| 1:05 pm | Adjuvant and Neoadjuvant Chemotherapy for Bladder Cancer Ronald B. Natale |
| 1:30 pm | Standard Chemotherapy and Novel Agents for Metastatic Bladder Cancer Matthew D. Galsky |
| 1:55 pm | Interactive Case Discussion |
| 2:20 pm | Postsession Survey and Closing Comments |
| 2:30 pm | Adjourn |